Could a common hormone beat dangerous Post-Surgery low blood pressure?
NCT ID NCT06487585
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether angiotensin II, a drug that narrows blood vessels, can safely and effectively treat dangerously low blood pressure after heart surgery. About 100 adults undergoing heart surgery with a heart-lung machine will receive the drug as a first-line treatment. Researchers will track complications like kidney injury and irregular heartbeat over 28 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Angiotensin II
What this could lead to
If successful, this could provide a new, more effective first-line option to stabilize blood pressure after heart surgery, potentially reducing serious complications like kidney injury and irregular heartbeat.
What could go wrong
This is a small, early-phase 4 trial with only 100 participants, so results may not apply to all patients. The drug may not outperform existing treatments and could have side effects like excessive blood pressure elevation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASODILATORY HYPOTENSION DURING OR AFTER CARDIAC SURGERY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Maryland St. Joseph Medical Center
RECRUITINGTowson, Maryland, 21204, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••